Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Characteristics of Grade 2 Disability in Indonesian Children with Leprosy: A Five-Year Multicenter Retrospective Study.

Gunawan H, Kamilia A, Menaldi S, et al. Clinical, cosmetic and investigational dermatology. 2021;
Download PDF
Publication

Disability Level, Physical Activity Limitations, Self-esteem and Self-efficacy of Persons Living with Leprosy in Selected States in Nigeria

Umunnah JO, Mmadieke OC, Amaechi IA, et al. Sierra Leone Journal of Biomedical Research. 2021; 13 (1) : 1-8.
Download PDF
Publication

Relevância do grau de incapacidade física como preditor do diagnóstico tardio em hanseníase: Uma revisão de escopo

Alves GMG, Almeida AGCDS, Licetti MM, et al. Research, Society and Development. Research, Society and Development. 2021; 10 (6) : e5410615399.
Download PDF
Publication

O diagnóstico tardio na perspectiva do itinerário terapêutico: grau 2 de incapacidade física na hanseníase

Hespanhol MCL, Domingues SM, Uchôa-Figueiredo LDR. FapUNIFESP (SciELO). Interface - Comunicação, Saúde, Educação. 2021;
Download PDF
Publication

Pure Neuritic Leprosy in Southern Kerala: Clinico-Epidemiological Characteristics and the Role of Peripheral Nerve Fine Needle Aspiration Cytology as a Diagnostic Aid

Mini G, Mathew PS, Suja V, et al. Indian Journal of Leprosy. 2021;
Download PDF
Publication

Validation of the Brazilian version of the WHODAS 2.0 for people affected by leprosy

de Sousa Almondes JG, de Castro SS, Nogueira P, et al. Lepra. Leprosy Review. 2021; 92 (1) : 47-58.
Download PDF
Publication

Physical disabilities caused by leprosy in 100 million cohort in Brazil.

Sanchez MN, Nery J, Pescarini J, et al. BMC infectious diseases. 2021; 21 (1) : 290.
Download PDF
Publication

Revised estimates of leprosy disability weights for assessing the global burden of disease: A systematic review and individual patient data meta-analysis.

Chandran S, Tiwari A, Lustosa A, et al. PLoS neglected tropical diseases. 2021; 15 (3) : e0009209.
Download PDF
Publication

Características demográficas e clínicas do grau de incapacidade física associadas ao diagnóstico e alta do tratamento da hanseníase

Ribeiro LCG, Da Rocha LO, Bolorino N, et al. Revista Eletronica Acervo Saude. Revista Eletrônica Acervo Saúde. 2021; 13 (2) : e6008.
Publication

Quality of life of leprosy patients in Sabah.

Gan T, Voo S. The Medical journal of Malaysia. 2021; 76 (1) : 56-60.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 8
  • Next page ››
Subscribe to Disability grading

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD